The Enhanced Games' Real Business Isn't Sports

The Enhanced Games will be held in Las Vegas, which is fitting. Vegas is where spectacle and commerce have always understood each other better than anywhere else, where the show is the mechanism through which money changes hands, and where nobody pretends otherwise. That transparency is, in its own strange way, the entire point.

Before a single starting block fires, the Enhanced Games — an openly pro-doping athletic competition founded by lawyer Aron D'Souza and backed by Peter Thiel, the Winklevoss twins, biotech billionaire Christian Angermayer, a Saudi prince, and Donald Trump Jr. — was valued at $1.2 billion. The event has no major sponsors. It plans to stream free on YouTube. The field, originally envisioned at thousands of athletes, will come in at under 100. The debut was pushed two years past its original target date. By every conventional sports-business metric, those are signs of strain.

They are not, however, signs that the people running this are confused about what they're building.

The Advertisement Wearing a Tracksuit

The clearest way to understand the Enhanced Games is to stop thinking of it as a sports property competing with the Olympics and start thinking of it as a consumer brand using sport as its media channel — the same way Red Bull does, except the product isn't an energy drink. It's testosterone therapy and supplements, which Enhanced quietly launched its consumer platform to sell in March 2026, right as the games were approaching.

The Athletic Interest video essay that broke this down put it cleanly: "The sports event isn't the product. The sports event is the ad."

That reframing explains everything that otherwise seems like dysfunction. Free streaming on YouTube isn't a revenue gap — it's reach maximization for an ad campaign. The absence of blue-chip sponsors isn't a credibility problem — it's irrelevant when the event itself is the promotional vehicle. The $1 million prize money isn't generosity; it's production budget for the most dramatic possible content.

The target audience, as described by the Enhanced Games' own positioning, is middle-aged men who feel the metabolic and physical slowdown of their forties, who already live in a world where testosterone replacement therapy advertises on sports podcasts and Ozempic gets discussed at dinner parties. The strategy is straightforward: put a credentialed 35-year-old swimmer in a lane, have him run a jaw-dropping time under documented enhancement, and let a million viewers ask themselves the obvious question.

This is not a novel playbook. Nike and Ineos spent tens of millions engineering Eliud Kipchoge's sub-two-hour marathon in 2019 — a performance that technically didn't count as an official record due to pacing and course conditions. The event was science as spectacle, spectacle as marketing. The Enhanced Games is the same architecture, different product, with the doping made explicit rather than merely suspected.

What the Athletes Are Actually Weighing

The athlete calculus here is genuinely complicated, and it deserves more than a paragraph.

Kristian Gkolomeev swam the 50-meter freestyle faster than any officially recognized time in history. That record will not appear in any record book because it was achieved under enhancement. What it did earn him, per the Athletic Interest breakdown, was the largest single paycheck of his career — by a significant margin. Gkolomeev spent 14 years as a professional swimmer, competed in four Olympics, and accumulated roughly $200,000 in total career earnings. The Enhanced Games paid $250,000 just for winning an event, plus appearance fees, plus a million-dollar bonus for the record.

That arithmetic is not complicated. It is, however, a transaction with consequences. Athletes who compete in the Enhanced Games are effectively trading their eligibility in sanctioned competition — World Aquatics, World Athletics, the Olympics — for a single large payout. Whether that trade makes sense depends entirely on where an athlete sits in their career arc, their realistic probability of future Olympic earnings, and their assessment of personal health risk under a monitored doping protocol.

James Magnussen, the Australian sprinter who became the games' first committed athlete after organizers heard him joking on a podcast — "I'll juice to the gills and break it within 6 months" — went through visible physical transformation in weeks. His swim times, notably, got worse. More muscle mass does not automatically make a swimmer faster through water. That's a useful data point about the gap between the Enhanced Games' marketing language and its biological premises.

The 5% Claim and What It Actually Means

The Enhanced Games are built on a central performance claim: that the approved protocol of testosterone, growth hormone, and peptides will improve athletes' performance by approximately 5%. That number does a lot of work in their promotional material.

Apply 5% to Usain Bolt's 9.58-second 100-meter world record — which has survived sixteen years of competition from athletes both clean and quietly doped — and you get 9.11 seconds. A more conservative reading of 5% improvement from Fred Kerley's personal best lands somewhere around 9.27 seconds. Either figure would shatter what most exercise physiologists consider a plausible ceiling for human sprint performance.

The problem is that testosterone and growth hormone demonstrably improve muscle mass, recovery time, and certain endurance metrics. Their effect on peak explosive output at already-elite levels of fast-twitch fiber recruitment is considerably murkier. Bolt's record didn't stand because nobody has ever tried doping in a sprint competition. It stood because the biomechanical and physiological variables that produced 9.58 were, as the video puts it, "a perfect collision of factors that are almost impossible to recreate." A world championship final, multiple elite competitors pushing each other, a once-in-a-generation athlete at the precise peak of his career.

None of that will be replicated in a Las Vegas casino, with or without a medical protocol.

The 5% figure reads more convincingly when applied to sports like swimming and weightlifting, where the performance ceiling is more directly tied to recoverable strength and less dependent on the specific neurological and mechanical conditions that produce sprint world records. That Gkolomeev actually swam a legitimately extraordinary time is the most substantive piece of evidence the Enhanced Games have produced. That it will not count in any recognized record book is, commercially, beside the point.

The Larger Pitch

The investor most worth reading carefully is Angermayer, whose February 2024 Substack post — described by the Athletic Interest analysis as reading "less like an investor thesis and more like a manifesto" — maps out a hierarchy of human enhancement markets in ascending order of disruption: body weight (already proven by Ozempic), sexual performance, muscle, cognition, emotional wellness through psychedelics, and ultimately transhumanism — brain-computer interfaces, Neuralink, the full integration of technology into biology.

Within this framework, the Enhanced Games are not a sports company. They are a public demonstration, a proof-of-concept event designed to normalize pharmaceutical self-optimization for a mass consumer market. The investment thesis requires breaking down the cultural and regulatory resistance to enhancement, and a sporting spectacle where enhanced athletes visibly outperform their prior selves is a more effective instrument for that purpose than a white paper.

Angermayer's stated view on AI is relevant context here: that artificial intelligence will render unaugmented humans economically obsolete, and that enhancement is the species-level response. "The only way to keep humans competitive is to enhance them," the thesis argues. Whether you read that as visionary or alarming probably depends on your prior relationship to technological acceleration. As an investment narrative framing a $1.2 billion valuation, it is, at minimum, coherent.

What We Don't Yet Know

The open questions are substantial. Whether the Enhanced Games can sustain athlete recruitment past its inaugural class — given the permanent career cost of participation in sanctioned sports — remains genuinely uncertain. Whether its consumer platform can build a commercially viable business on the back of what is, legally in most jurisdictions, a complex regulatory landscape for testosterone therapy and performance supplements is another. The organizational challenges have already pushed the timeline two years and compressed the field by a factor of twenty or more from initial projections.

The Enhanced Games might be a durable institution. It might be a single, extremely expensive content event that seeds a consumer brand. It might be neither, if the legal and regulatory environment tightens around the products it's selling.

What it unambiguously is, right now, is a live test of whether openly transhumanist capital can manufacture mainstream cultural permission for pharmaceutical enhancement — using athletic spectacle as the mechanism of persuasion.

The marketing is sophisticated. The business logic is internally consistent. The biological claims are, in at least some cases, more aggressive than the science clearly supports. The athletes who show up have made considered, if irreversible, financial decisions. And the investors backing it are betting that we are, in fact, at the early edge of something much larger than a sporting event.

Vegas seems like the right venue for that kind of wager.

---

Marcus Tate is Sports Desk Editor at BuzzRAG.